Ignite Creation Date:
2024-05-06 @ 4:02 PM
Last Modification Date:
2024-10-26 @ 2:02 PM
Study NCT ID:
NCT04851834
Status:
TERMINATED
Last Update Posted:
2022-12-20
First Post:
2021-04-08
Brief Title:
NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian Bladder Cancer and in Combination With Temozolomide in High-grade Glioma
Sponsor:
Xennials Therapeutics Australia Pty Ltd
Organization:
Xennials Therapeutics Australia Pty Ltd
Organization Data
Organization:
Xennials Therapeutics Australia Pty Ltd
Class:
INDUSTRY
Study ID:
XNTR-20-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xennials Therapeutics Australia Pty Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pinotbio Inc | INDUSTRY |